Docs Who Lift
Docs Who Lift
Add to My Podcasts
Episodes
About
Reviews
Promote
More Than Weight Loss? GLP-1s and Cardiovascular Risk
11 minutes
Posted Aug 3, 2025 at 9:09 pm.
0:00
11:16
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Monjaro just dropped hot new trial results and they might show it helps you live longer. We break down the Surpass CVOT, compare it to Trulicity, and explain what this all means for your heart, kidneys, and overall health.
Previous
Semaglutide vs. Tirzepatide: Are We Closing the Gap?
Next
CVS Pulled the Plug on Zepbound?!
← See all 158 episodes of Docs Who Lift